Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950170-25-014245·OptimizeRx Corp
Schedule 13D ownership disclosure
OptimizeRx Corp
Common Stock, par value $0.001 · CUSIP: 68401U204
Event date: 2025-02-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Whetstone Capital Advisors, LLCReported CIK 0001607278
Shares: 1,508,303 · Class: 8.2%
- David Atterbury
Shares: 1,508,303 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-014245
- Form type
- SCHEDULE 13D
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Feb 05, 2025
- Reporting period
- Feb 03, 2025
- Description
- Schedule 13D beneficial ownership